An emerging strategy to enhance the efficacy of immune checkpoint blockade in relapsed/refractory cancers is increasing immunogenic cell death via combination with cytotoxic therapies. Understanding the effects of cytotoxic and immunotherapeutic agents on immune cell populations will enable improved mechanism-based design of combination therapies to maximum efficacy and minimum toxicity..
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894576 | PMC |
| http://dx.doi.org/10.1158/2643-3230.BCD-21-0130 | DOI Listing |
Publication Analysis
Top Keywords
checkpoint blockade
8
blockade chemotherapy
4
chemotherapy combination
4
combination aml?
4
aml? emerging
4
emerging strategy
4
strategy enhance
4
enhance efficacy
4
efficacy immune
4
immune checkpoint
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!